- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01414179
NESCAV Nutrition Environment and Cardiovascular Health (NESCAV)
Nutrition Environnement et Santé Cardio Vasculaire NESCAV
Introduction. The cardiovascular diseases, at the origin of 4 deaths out of 10, remain the leading cause of mortality in Europe. According to WHO, this tendency will spread in 2020 on a worldwide scale. These pathologies are avoidable on the whole by the adoption of healthy lifestyles. To prevent occurred of the cardiovascular affections is, more than ever, a major goal of Public health. The transborder "Great Area", localised zone in the middle of Europe between the very high cardiovascular risks of the North and the weaker risks of the South, constitutes a zone privileged for the action against the cardiovascular diseases. However, there to date does not exist any joint action in this geographical area. The Public Research centre of the Health of the Grand-Duchy of Luxembourg, the School of Public health of the University of Liege, the Clinical Center of Investigation of the University hospital of Nancy and the University hospital of the Saar wish to be linked and mutualiser their means available and their complementary competences in order to evaluate and to act on the cardiovascular health of the citizens of the "Great Area". Over one 3 years period the Nutrition project, Environment and Cardiovascular Health (NESCAV) aims at creating on the level of the Great Area a transborder alliance of prevention and promotion of cardiovascular health. This great multicentric transverse investigation and poly-set of themes will make it possible to collect relevant data on cardiovascular health of the population of the Great area.
Objective of this biomedical research project: It is about multicentric, transverse a Européenne epidemiological study aiming, through biological questionnaires and analyses, to collect information on the cardiovascular risk factors within the Great Area.
Study Overview
Status
Conditions
Detailed Description
Study Type
Enrollment (Anticipated)
Contacts and Locations
Study Contact
- Name: Celine Hertz
- Phone Number: +33 3 83 15 73 12
- Email: cel.hertz@chu-nancy.fr
Study Locations
-
-
-
Vandoeuvre lès Nancy, France, 54500
- Recruiting
- Centre médecine Preventive
-
Contact:
- Celine Hertz
- Phone Number: +33 3 83 15 73 12
- Email: cel.hertz@chu-nancy.fr
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Inclusion Criteria:
- men or women aged 18 till 69 years old
- living in Lorraine since 5 years
- speaking and understanding French language
- having signed the assent
- Having a social security number
Exclusion Criteria:
- taking part of the study refusal
- signature assent refusal
- pregancy
- minor people
- People under supervision or under trusteeship
Study Plan
How is the study designed?
Design Details
- Observational Models: Ecologic or Community
- Time Perspectives: Prospective
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Faiez ZANNAD, PU-PH, CIC-P
Study record dates
Study Major Dates
Study Start
Primary Completion (Anticipated)
Study Completion (Anticipated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
- 2010-A00549-30
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Cardiovascular Pathology
-
Central Hospital, Nancy, FranceNot yet recruitingIn-depth ECG Analysis for the Extraction of Biomarkers of Cardiac Mechanical Dispersion (AFICIONADO)Cardiovascular PathologyFrance
-
Universidad Católica San Antonio de MurciaCompleted
-
University of North Carolina, Chapel HillNational Heart, Lung, and Blood Institute (NHLBI); University of California... and other collaboratorsNot yet recruitingCardiovascular DiseaseUnited States
-
Massachusetts General HospitalBrigham and Women's HospitalCompletedCardiovascular DiseaseUnited States
-
Parc de Salut MarCompleted
-
University of AberdeenCompleted
-
Leiden University Medical CenterCompletedCardiovascular DiseaseNetherlands
-
United States Department of Agriculture (USDA)Ocean Spray, Inc.Completed
-
University of OsloUllevaal University HospitalCompleted
-
Pronova BioPharmaCompleted